We have identified a weak partial agonist activity of DOH for androgen receptor (AR) [5] and estrogen receptor alpha (ERα) [6] in responsive cancer cell culture models, whereas D and DA acted as novel AR and ERα antagonists/degraders and apoptosis inducers [4, 5, 6]. Here, AR is linked to cancer.